Cargando…
CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells
INTRODUCTION: Radioresistance is a major challenge in lung cancer radiotherapy, and new radiosensitizers are urgently needed. Estrogen receptor β (ERβ) is involved in the progression of non-small cell lung cancer (NSCLC), however, the role of ERβ in the response to radiotherapy in lung cancer remain...
Autores principales: | Li, Hang, Che, Jun, Jiang, Mian, Cui, Ming, Feng, Guoxing, Dong, Jiali, Zhang, Shuqin, Lu, Lu, Liu, Weili, Fan, Saijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499972/ https://www.ncbi.nlm.nih.gov/pubmed/32943060 http://dx.doi.org/10.1186/s12964-020-00571-4 |
Ejemplares similares
-
LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR‐449b‐5p
por: Zhang, Shuqin, et al.
Publicado: (2020) -
CLPTM1L Is Overexpressed in Lung Cancer and Associated with Apoptosis
por: Ni, Zhenhua, et al.
Publicado: (2012) -
SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
por: Jin, Yuxiao, et al.
Publicado: (2021) -
CLPTM1L Is a Novel Putative Oncogene Promoting Tumorigenesis in Oral Squamous Cell Carcinoma
por: Hou, Yunwen, et al.
Publicado: (2021) -
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus
por: Mobuchon, Lenha, et al.
Publicado: (2017)